Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury

Kidney International

Volumn 85, Issue 3, 2014, Pages 570-578

  Nakayama, Yosuke ^a   Ueda, Seiji ^a   Yamagishi, Sho Ichi ^a   Obara, Nana ^a   Taguchi, Kensei ^a   Ando, Ryotaro ^a   Kaida, Yusuke ^a   Iwatani, Ryuji ^a   Kaifu, Kumiko ^a   Yokoro, Miyuki ^a   Toyonaga, Maki ^a   Kusumoto, Takuo ^a   Fukami, Kei ^a   Okuda, Seiya ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ADMA; DDAH 1; ischemia reperfusion injury; oxidative stress; renal capillary loss

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; DIMETHYLARGININASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G),N(G) DIMETHYLARGININE; PROTEIN ARGININE METHYLTRANSFERASE; ACETYLCYSTEINE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CREATININE; NITROGEN; UREA; AMIDASE; ARGININE; N,N-DIMETHYLARGININE;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; KIDNEY DYSFUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE NECROSIS; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; BIOACCUMULATION; BLOOD LEVEL; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DISEASE EXACERBATION; KIDNEY INJURY; KIDNEY PARENCHYMA; UREA NITROGEN BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; KIDNEY; METABOLISM; PATHOLOGY; VASCULARIZATION;

ACETYLCYSTEINE; AMIDOHYDROLASES; ANIMALS; ARGININE; KIDNEY; MALE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; REPERFUSION INJURY;

EID: 84895194188     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2013.398     Document Type: Article

References (53)

1. Ali T, Khan I, Simpson W et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 2007; 18: 1292-1298
2. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996; 275: 1489-1494
3. Xue JL, Daniels F, Star RA et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 2006; 17: 1135-1142
4. Sutton TA, Fisher CJ, Molitoris BA. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 2002; 62: 1539-1549
5. Bonventre JV, Weinberg JM. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 2199-2210
6. Liu H, Jia Z, Soodvilai S et al. Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury. Am J Physiol Renal Physiol 2008; 295: F942-F949
7. Conger JD, Weil JV. Abnormal vascular function following ischemiareperfusion injury. J Investig Med 1995; 43: 431-442
8. Brodsky SV, Yamamoto T, Tada T et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 2002; 282: F1140-F1149
9. Schramm L, Heidbreder E, Schmitt A et al. Role of L-arginine-derived NO in ischemic acute renal failure in the rat. Ren Fail 1994; 16: 555-569
10. Chintala MS, Chiu PJ, Vemulapalli S et al. Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 1993; 348: 305-310
11. Matsumura Y, Nishiura M, Deguchi S et al. Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats. J Pharmacol Exp Ther 1998; 287: 1084-1091
12. Kurata H, Takaoka M, Kubo Y et al. Protective effect of nitric oxide on ischemia/reperfusion-induced renal injury and endothelin-1 overproduction. Eur J Pharmacol 2005; 517: 232-239
13. Satake A, Takaoka M, Nishikawa M et al. Protective effect of 17betaestradiol on ischemic acute renal failure through the PI3K/Akt/eNOS pathway. Kidney Int 2008; 73: 308-317
14. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000; 20: 2032-2037
15. Ueda S, Yamagishi S, Okuda S. New pathways to renal damage: role of ADMA in retarding renal disease progression. J Nephrol 2010; 23: 377-386
16. Zoccali C. The endothelium as a target in renal diseases. J Nephrol 2007; 20(Suppl 12): S39-S44
17. Böger RH. The pharmacodynamics of L-arginine. J Nutr 2007; 137: 1650S-1655
18. Abedini S, Meinitzer A, Holme I et al. Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients. Kidney Int 2010; 77: 44-50
19. Kaida Y, Ueda S, Yamagishi S et al. Proteinuria elevates asymmetric dimethylarginine levels via protein arginine methyltransferase-1 overexpression in a rat model of nephrotic syndrome. Life Sci 2012; 91: 301-305
20. Lin KY, Ito A, Asagami T et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation 2002; 106: 987-992
21. Ishibashi Y, Yamagishi S, Matsui T et al. Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level. Metabolism 2012; 61: 1067-1072
22. Dudzinski DM, Michel T. Life history of eNOS: partners and pathways. Cardiovasc Res 2007; 75: 247-260
23. Yamamoto T, Tada T, Brodsky SV et al. Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am J Physiol Renal Physiol 2002; 282: F1150-F1155
24. Tyagi N, Sedoris KC, Steed M et al. Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 2005; 289: H2649-H2656
25. Luo Z, Teerlink T, Griendling K et al. Angiotensin II and NADPH oxidase increase ADMA in vascular smooth muscle cells. Hypertension 2010; 56: 498-504
26. Basile DP. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int 2007; 72: 151-156
27. Rodr?guez-Crespo I, Gerber NC, Ortiz de Montellano PR. Endothelial nitricoxide synthase. Expression in Escherichia coli, spectroscopic characterization, and role of tetrahydrobiopterin in dimer formation. J Biol Chem 1996; 271: 11462-11467
28. Saito M, Miyagawa I. Real-time monitoring of nitric oxide in ischemiareperfusion rat kidney. Urol Res 2000; 28: 141-146
29. Rodr?guez F, Nieto-Ceron S, Fenoy FJ et al. Sex differences in nitrosative stress during renal ischemia. Am J Physiol Regul Integr Comp Physiol 2010; 299: R1387-R1395
30. McDonald LJ, Murad F. Nitric oxide and cyclic GMP signaling. Proc Soc Exp Biol Med 1996; 211: 1-6
31. Caglar K, Yilmaz MI, Sonmez A et al. ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease. Kidney Int 2006; 70: 781-787
32. Yilmaz MI, Saglam M, Sonmez A et al. Improving proteinuria, endothelial functions and asymmetric dimethylarginine levels in chronic kidney disease: ramipril vs. valsartan. Blood Purif 2007; 25: 327-335
33. Ciechanover A. The ubiquitin-proteasome proteolytic pathway. Cell 1994; 79: 13-21
34. Goldberg AL. Protein degradation and protection against misfolded or damaged proteins. Nature 2003; 426: 895-899
35. Eid HM, Lyberg T, Arnesen H et al. Insulin and adiponectin inhibit the TNFalpha-induced ADMA accumulation in human endothelial cells: the role of DDAH. Atherosclerosis 2007; 194: e1-e8
36. Feng X, Yan J, Wang Y et al. The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells. Mol Immunol 2010; 47: 2388-2396
37. Itoh M, Takaoka M, Shibata A et al. Preventive effect of lactacystin, a selective proteasome inhibitor, on ischemic acute renal failure in rats. J Pharmacol Exp Ther 2001; 298: 501-507
38. Siedlecki AM, Jin X, Thomas W et al. RGS4, a GTPase activator, improves renal function in ischemia-reperfusion injury. Kidney Int 2011; 80: 263-271
39. Sutton TA, Mang HE, Campos SB et al. Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol 2003; 285: F191-F198
40. Suschek CV, Schnorr O, Hemmrich K et al. Critical role of L-arginine in endothelial cell survival during oxidative stress. Circulation 2003; 107: 2607-2614
41. Ziche M, Parenti A, Ledda F et al. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ Res 1997; 80: 845-852
42. Murohara T, Witzenbichler B, Spyridopoulos I et al. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol 1999; 19: 1156-1161
43. Smith CL, Birdsey GM, Anthony S et al. Dimethylarginine dimethylaminohydrolase activity modulates ADMA levels, VEGF expression, and cell phenotype. Biochem Biophys Res Commun 2003; 308: 984-989
44. Jacobi J, Sydow K, von Degenfeld G et al. Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis. Circulation 2005; 111: 1431-1438
45. Di Giorno C, Pinheiro HS, Heinke T et al. Beneficial effect of N-acetylcysteine on renal injury triggered by ischemia and reperfusion. Transplant Proc 2006; 38: 2774-2776
46. Dayoub H, Achan V, Adimoolam S et al. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation 2003; 108: 3042-3047
47. Kielstein JT, Impraim B, Simmel S et al. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 2004; 109: 172-177
48. Matsuguma K, Ueda S, Yamagishi S et al. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease. J Am Soc Nephrol 2006; 17: 2176-2183
49. Ueda S, Kato S, Matsuoka H et al. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Circ Res 2003; 92: 226-233
50. Yokoro M, Suzuki M, Murota K et al. Asymmetric dimethylarginine, an endogenous NOS inhibitor, is actively metabolized in rat erythrocytes. Biosci Biotechnol Biochem 2012; 76: 1334-1342
51. Hohenstein B, Braun A, Amann KU et al. A murine model of site-specific renal microvascular endothelial injury and thrombotic microangiopathy. Nephrol Dial Transplant 2008; 23: 1144-1156
52. Hagiwara M, Bledsoe G, Yang ZR et al. Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress. Am J Physiol Renal Physiol 2008; 295: F1735-F174
53. Wang W, Faubel S, Ljubanovic D et al. Endotoxemic acute renal failure is attenuated in caspase-1-deficient mice. Am J Physiol Renal Physiol 2005; 288: F997-1004.